The independent source for health policy research, polling, and news.
Rachel Bluth was a correspondent for ºÚÁϳԹÏÍø News until February 2023.
Showing 101 - 120 of 162
A new study in JAMA Surgery finds that a large sample of published medical research failed to disclose details on the financial relationships between medical device makers and physicians. Changes in the disclosure process could close this loop.
Rep. Chris Collins talked one time too many, according to federal prosecutors who on Wednesday charged him with violating insider trading laws.
The Trump administration signals it is willing to consider such a move if it is carefully tailored to focus solely on specific situations where a high-priced drug is made by one company.
Consumers, beware: Data brokers compile health and frailty profiles that have wide-ranging applications for drug companies, advertisers, insurers and other buyers.
Oral arguments are heard in a legal challenge regarding the state of Kentucky’s requirement that adults who gained Medicaid coverage under the Affordable Care Act’s expansion prove that they work or volunteer in order to get health coverage.
Even voters who say they are more enthusiastic about voting in this congressional election than in past ones are not motivated by any specific issue. But, according to a poll out Thursday, health care policies rank high among topics voters want candidates to address.
For people who buy their health coverage rather than get it from the government or through work, Charlottesville, Va., has claimed the title of having the country’s highest health insurance costs, and its residents are fighting back.
Surgeon General Jerome Adams urged more people to carry the drug naloxone, a lifesaving treatment for opioid overdoses. But this policy is tricky to implement.
Most people who buy insurance on the individual market say they are motivated by concerns about high medical bills and a desire for peace of mind — not the law’s requirement that they have coverage, according to a new poll from the Kaiser Family Foundation.
Research out Monday offers evidence that advertising for e-cigarettes and other new tobacco products, which aren’t subject to the same restrictions that apply to the marketing traditional cigarettes, is stoking use among adolescents and young-adult smokers.
Almost three-quarters of Americans think the pharmaceutical industry has too much power in the nation’s capital, according to the Kaiser Family Foundation.
As states brace for insurance market instability, some — like Maryland — take aggressive action.
Months of reporting and rich hospital data portray life in the worst asthma hot spot in one of the worst asthma cities: Baltimore. The medical system knows how to help. But there’s no money in it.
Ineligible for subsidies, a Tennessee woman quit her job to get an affordable health care premium. Conventional steps — such as maxing out your 401(k) contribution each year — may also do the job, financial planners say.
From infections linked to the storm to trying to treat people with chronic diseases in damaged clinics, health officials on this American territory struggle to stay ahead of the needs.
The clinics, which serve many poor people, are tightening spending in case Congress doesn’t approve new funding for them before the government’s 2018 fiscal year starts Sunday.
Hundreds of protesters were turned away from the Senate’s public hearing on the Graham-Cassidy bill to replace the Affordable Care Act, but they made their feelings known outside the door.
The Senate health committee is putting aside partisan bickering this month to seek a legislative remedy to a possible spike in Obamacare premiums this fall.
State leaders tell senators that federal dollars are needed this fall to keep insurers participating in Obamacare next year and prevent big hikes in premiums.
Making needed fixes to Obamacare before next year may be more difficult — and expensive — than Senate leaders think, state insurance commissioners suggested at a Senate hearing Wednesday.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF